Announcements Trials
Browse Landscape

Status

No longer available 1Available 1

Sponsor Class

OTHER 2

Study Type

Interventional 22Observational 3Expanded_access 2

Sponsor

Cancer Type

Endocrine 2Head & Neck 1CNS 1

Conditions

Insulinoma 2Thyroid cancer, medullary 1Pheochromocytoma 1Paraganglioma 1Neuroblastoma 1Hypoglycemia 1Hyperinsulinism 1Congenital Hyperinsulinism 1Carcinoid Tumor 1Beckwith-Wiedemann Syndrome 1

Interventions

3-Iodobenzylguanidine 9Amifampridine 6nilotinib 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 5trametinib 4pembrolizumab 4gallium 68 PSMA-11 4fludarabine 4elotuzumab 4dabrafenib 4Nivolumab 4Bortezomib 4Afatinib 4venetoclax 3regorafenib 3midostaurin 3fludarabine phosphate 3TIC10 compound 3Sunitinib 3Prednisone 3Lenalidomide 3Ipilimumab 3Everolimus 3Dexamethasone 3Crizotinib 3Capecitabine 3Axitinib 3Alpelisib 3Abiraterone Acetate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × fluorodopa F 18 × Clear all
NCT01916148 2026-04-27

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Children's Hospital of Philadelphia

Available
Endocrine

Beckwith-Wiedemann Syndrome, Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡